Dr. Murugavel M. Muthusamy, MD

Dr. Muthusamy practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Dr. Muthusamy's NPI, 1467420760, was assigned on March 10, 2006. Dr. Muthusamy holds Indiana license 01040972A.

Dr. Muthusamy's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Dr. Muthusamy's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. Dr. Muthusamy is also affiliated with Parkview Whitley Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Muthusamy to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muthusamy practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Muthusamy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Muthusamy's licenses on file in 3 states: Indiana, Illinois and Wisconsin.

CMS data shows 376 Medicare services from Dr. Muthusamy across 5 procedure codes in 2024, for 110 Medicare patients. Medicare paid $31,466 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Muthusamy in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have cancer, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muthusamy's median patient age at 72, with 42% women.

In 2024, Dr. Muthusamy wrote 654 Medicare Part D claims for 138 patients. 85% of them were for generic drugs. CMS names the drug for 490 of them, across 13 drugs with 11 or more claims each, at $223,221 in total drug cost. In 2023, CMS named 81 claims across 5 drugs.

Dr. Muthusamy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 908 general payments to Dr. Muthusamy from 74 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Incyte Corporation paid the most, $4,595.